In a bold talk, drug policy reformist Ethan Nadelmann makes an impassioned plea to end the “backward, heartless, disastrous” movement to stamp out the drug trade. He gives two big reasons we should focus on intelligent regulation instead.
via Drug Policy Alliance:
Twenty years ago, Ethan Nadelmann left his teaching position at Princeton University to become a full-time advocate for ending the drug war. As the founding executive director of the Drug Policy Alliance (DPA), the largest and most influential organization promoting drug policies grounded in science, compassion, health and human rights, Ethan’s vision and leadership have had a monumental impact on public opinion and changed the course of history.
Take a few minutes, as soon as you can, to hear Ethan Nadelmann’s newly releasedTED Talk that’s featured as today’s lead item at TED.com. There is a good reason for the standing ovation Ethan received at the conclusion. The ideas he presents are provocative, enlightening and becoming more mainstream than anyone could have imagined when he began his activism more than two decades ago.
The Drug Policy Alliance has reformed state and federal laws involving drug sentencing, access to sterile syringes to reduce HIV/AIDS, addiction treatment, prevention of overdose fatalities, and all aspects of marijuana policy. DPA and its lobbying arm, Drug Policy Action, played an instrumental role in securing monumental drug policy reform victories in the recent midterm elections, including marijuana legalization in Oregon, Alaska and Washington, D.C., marijuana decriminalization in New Mexico, medical marijuana in Guam, and groundbreaking criminal justice and sentencing reforms in New Jersey and California.
Ethan is drug policy advisor to George Soros and other prominent philanthropists as well as elected officials ranging from mayors, governors and state and federal legislators in the U.S. to presidents and cabinet ministers outside the U.S. He and the Drug Policy Alliance have worked closely with the Global Commission on Drug Policy, whose members include global leaders and luminaries like Sir Richard Branson and Kofi Annan, to break the taboo on public discussion of non-prohibitionist drug policies.